Japan· JP-1319720Y2179
精製ヒアルロン酸ナトリウム
A hyaluronic acid product containing 精製ヒアルロン酸ナトリウム, registered in Japan by 科研製薬, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Hyaluronic acid is registered in 7 of 19 countries.
Countries holding a registration under ATC M09AX01 (hyaluronic acid), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 4 of them publish a price we can compare per daily dose
Hyaluronic acid · ATC M09AX01
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Japan
- Polandprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- 精製ヒアルロン酸ナトリウム
- Manufacturer
- 科研製薬
- Country
- Japan (JP)
- ATC code
- M09AX01
- ATC class
- Hyaluronic acid
- Defined daily dose
- 3.6 mg, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for hyaluronic acid.
Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hyaluronic acid · interactions on record
6 records
- 6 moderate
Most severe, free to view
- BenzalkoniumD08AJ01moderate
- CetylpyridiniumD08AJ03moderate
- CetylpyridiniumD09AA07moderate
- BenzalkoniumD09AA11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M09AX01
Hyaluronic acid, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6ceda97-b55b-4f7f-b774-0d931b3cb824 GET /v1/drugs/f6ceda97-b55b-4f7f-b774-0d931b3cb824?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．３％５ｍＬ１瓶",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "1319720Y2179",
"category": "外用薬",
"price_yen": 178.1,
"generic_name": "精製ヒアルロン酸ナトリウム",
"product_name_jp": null,
"therapeutic_class": "1319",
"transitional_expiry": null
}See everything about hyaluronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.